News and Updates

The Pharmacy Benefits and Advisory Committee (PBAC), consisting of clinical subject matter experts within Michigan Medicine and the University of Michigan, meets regularly to review and approve changes to the Prescription Drug Plan formulary. This page provides updates regarding the plan’s formulary, changes to coverage policies, and other relevant Prescription Drug Plan news for plan members. Check this page frequently for the latest information.

November 2019

Effective November 1, 2019, the following changes will be made to the Prescription Drug Plan’s formulary. These changes will be reflected in the plan’s next bi-monthly print formulary. Review the formulary.

New Drug Products Added to Formulary

  • Semaglutide (Rybelsus) – Tier 3, PA, QL
  • Pitolisant (Wakix) – Tier 2, Specialty, PA, QL
  • Istradefylline (Nourianz) – Tier 3, PA, QL
  • Lamivudine/Tenofovir (Temixys) – Tier 3, Specialty, QL
  • Glucagon (Gvoke Hypopen, PFS) – Tier 2, QL

New Generics Added to Formulary

Nitisinone (Generic for Orfadin)

October 2019

Effective October 1, 2019, the following changes will be made to the Prescription Drug Plan’s formulary. These changes will be reflected in the plan’s next bi-monthly print formulary. Review the formulary.

New Drug Products Added to Formulary

  • Upadacitinib (Rinvoq) – Specialty, Tier 2, PA, QL
  • Entrectinib (Rozlytrek) – Specialty, Tier 2, PA, QL
  • Fedratinib (Inrebic) – Specialty, Tier 3, PA, QL
  • Pexidartinib (Turalio) – Specialty, Tier 2, PA, QL
  • Tegaserod (Zelnorm) – Tier 3, PA, QL
  • Lefamulin (Xenleta) –Tier 3, PA, QL
  • C1 esterase inhibitor (Ruconest) – Specialty, Tier 2, PA

New Generics Added to Formulary

  • Posaconazole (Generic for Noxafil)
  • Triamterene (Generic for Dyrenium)

September 2019

Effective September 1, 2019, the following changes will be made to the Prescription Drug Plan’s formulary. These changes will be reflected in the plan’s next bi-monthly print formulary. Review the formulary.

New Drug Products Added to Formulary

  • Bremelanotide (Vyleesi) – Tier 3, PA, QL
  • Selinexor (Xpovio) – Tier 2, Specialty, PA, QL
  • Darolutamide (Nubeqa) – Tier 3, Specialty, PA, QL
  • Glucagon Nasal Powder (Baqsimi) – Tier 2, QL

New Generics Added to Formulary

  • Pregabalin (Generic for Lyrica)
  • Ramelteon (Generic for Rozerem)

August 2019

Effective August 1, 2019, the following changes will be made to the Prescription Drug Plan’s formulary. These changes will be reflected in the plan’s next bi-monthly print formulary. Review the formulary.

New Drug Products Added to Formulary

  • Solriamfetol (Sunosi) – Tier 3, PA, QL
  • Tafamidis (Vyndaqel, Vyndamax) – Tier 2, Specialty, PA, QL
  • Alpelisib (Piqray) –Tier 2, Specialty, PA, QL
  • Mepolizumab (Nucala) – Tier 3, Specialty, PA, QL
  • Amifampridine (Ruzurgi) – Tier 2, Specialty, PA, QL
  • Midazolam Nasal Spray (Nayzilam) – Tier 2, PA, QL

New Generics Added to Formulary

  • Bosentan (Generic for Tracleer)
  • Mesalamine (Generic for Delzicol)
  • Mifepristone (Generic for Mifeprex)
  • Scopolamine Patch (Generic for Transderm-Scopolamine)

      .